Access to appropriate treatments for patients with serious infections; Medicare coverage of home-based antimicrobial infusions; medical liability reform; appropriate payment for physician services.
Antibiotic development; strengthening U.S. antimicrobial resistance efforts, including surveillance, prevention and control, data collection and research; antimicrobial stewardship; antimicrobials in agriculture
Evidence-based practices and policies to prevent and control health care-associated infections (HAIs)
Ensuring that the U.S. and global response to HIV/AIDS and tuberculosis (TB) is informed by science and social justice.
Supporting national immunization programs for children, adolescents, and adults, including health care workers; advancing research and development of new and improved vaccines.
Influenza, other emerging infections, and bio-threats; U.S. preparedness and response, public health and research efforts, countermeasures (vaccines, drugs and diagnostics), non-therapeutic control measures
Advancing biomedical and public health research priorities; supporting infrastructure that enables and strengthens ID research, clinical, and prevention efforts
Developing and maintaining a workforce of ID clinicians, researchers, and public health experts.
Funding for domestic and international ID programs, including antimicrobial resistance; immunization; drug, vaccine, and diagnostics development; and prevention and treatment of new and emerging infections.
IDSA members and the public can quickly contact your congressional representatives through our Advocacy Center to weigh in on policy priorities.